| Entire population (n = 739) | ||
---|---|---|---|
Success (n = 619) | Failed (n = 120) | P value | |
Age (years) | 67 ± 13 | 69 ± 13 | 0.14 |
Gender (male) | 568 (92) | 107 (89) | 0.38 |
Hypertension | 467 (75) | 96 (80) | 0.35 |
DM | 265 (43) | 48 (40) | 0.61 |
Hyperlipidemia | 267 (43) | 53 (44) | 0.84 |
Prior stroke | 51 (8) | 11 (9) | 0.72 |
PAD | 34 (6) | 11 (9) | 0.14 |
Smoking | 253 (41) | 47 (39) | 0.76 |
Prior MI | 135 (22) | 24 (20) | 0.72 |
Prior PCI | 317 (51) | 66 (55) | 0.49 |
Prior CABG | 61 (10) | 15 (13) | 0.41 |
LVEF (%) | 49 ± 12 | 48 ± 13 | 0.61 |
eGFR, MDRDc (ml/min) | 84 ± 33 | 76 ± 34 | 0.01 |
LDL (mg/dl) | 102 ± 35 | 97 ± 32 | 0.19 |
HbA1C (%) | 8.0 ± 3.8 | 7.6 ± 1.7 | 0.51 |
Location of CTO | |||
 LAD | 271 (44) | 46 (38) | 0.31 |
 LCx | 159 (26) | 37 (31) | 0.26 |
 RCA | 293 (47) | 63 (53) | 0.32 |
J CTO score | 2.45 ± 1.00 | 2.55 ± 0.96 | 0.32 |
MVD | 501 (81) | 106 (88) | 0.07 |
Lesion length (mm) | 38 ± 18 | 32 ± 11 | 0.01 |
Lesion width (mm) | 3.2 ± 3.6 | 3.0 ± 0.5 | 0.73 |
Primary retrograde | 48 (8) | 8 (7) | 0.34 |